(19)
(11) EP 1 519 738 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.04.2009 Bulletin 2009/17

(45) Mention of the grant of the patent:
10.12.2008 Bulletin 2008/50

(21) Application number: 03724185.8

(22) Date of filing: 24.04.2003
(51) International Patent Classification (IPC): 
A61K 36/185(2006.01)
A61K 36/81(2006.01)
A61P 25/06(2006.01)
 A61K 36/67(2006.01)
A61P 25/00(2006.01)
(86) International application number:
PCT/US2003/012593
(87) International publication number:
WO 2004/002507 (08.01.2004 Gazette 2004/02)

(54)

HERBAL COMPOSITION FOR TREATING OR ALLEVIATING VASCULAR HEADACHES, NEUROLOGICAL CONDITIONS AND NEURODEGENERATIVE DISEASES

KRÄUTERZUSAMMENSETZUNG ZUR BEHANDLUNG ODER LINDERUNG VON MIGRÄNEKOPFSCHMERZEN, NEUROLOGISCHEN ZUSTÄNDEN UND NEURODEGENERATIVEN ERKRANKUNGEN

COMPOSITION MEDICINALE AFIN DE TRAITER OU DE SOULAGER DES DOULEURS VASCULAIRES, DES CONDITIONS NEUROLOGIQUES ET DES MALADIES NEURODEGENERATIVES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 26.06.2002 US 180264

(43) Date of publication of application:
06.04.2005 Bulletin 2005/14

(73) Proprietors:
  • Chada, Murali Krishna
    Sterling VA 20164 (US)
  • Kuppam, Chandrasekhara Rao
    Kukatpally, Hyderabad 500072 (IN)

(72) Inventor:
  • Kuppam, Chandrasekhara Rao
    Kukatpally, Hyderabad 500072 (IN)

(74) Representative: Molnia, David 
df-mp Fünf Höfe Theatinerstrasse 16
80333 München
80333 München (DE)


(56) References cited: : 
WO-A-99/62531
US-A- 6 080 401
 DE-A- 19 858 741
US-A1- 2002 136 783
   
  • DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; June 1998 (1998-06) KURMA S RAO ET AL: "Anti-inflammatory and hepatoprotective activities of fruits of Moringa pterygosperma Gaertn." Database accession no. PREV199900233223 XP002253256 & INDIAN JOURNAL OF NATURAL PRODUCTS, vol. 14, no. 1, June 1998 (1998-06), pages 3-10, ISSN: 0970-129X
  • DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991 CACERES A ET AL: "PHARMACOLOGICAL PROPERTIES OF MORINGA-OLEIFERA 3. EFFECT OF SEED EXTRACTS IN THE TREATMENT OF EXPERIMENTAL PYODERMIA" Database accession no. PREV199293097031 XP002253257 & FITOTERAPIA, vol. 62, no. 5, 1991, pages 449-450, ISSN: 0367-326X
  • DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 1989 HOU C Y ET AL: "[Studies on the chemical constituents of Piper macropodum C.DC]" Database accession no. NLM2618672 XP002253258 & YAO XUE XUE BAO = ACTA PHARMACEUTICA SINICA. CHINA 1989, vol. 24, no. 10, 1989, pages 789-792, ISSN: 0513-4870
  • DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; June 1996 (1996-06) SÜSS R ET AL: "[Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract]" Database accession no. NLM8767662 XP002253259 & DER HAUTARZT;ZEITSCHRIFT FUR DERMATOLOGIE, VENEROLOGIE, UND VERWANDTE GEBIETE. GERMANY JUN 1996, vol. 47, no. 6, June 1996 (1996-06), pages 459-461, ISSN: 0017-8470
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).